title: Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy.
authors.affiliation: Hopital Edouard Herriot, Universite Claude Bernard, Lyon, France.
authors.forename: Maurice
authors.initials: M
authors.lastname: Laville